With 78% Ownership in Axogen, Inc. (NASDAQ:AXGN), Institutional Investors Have a Lot Riding on the Business
With 78% Ownership in Axogen, Inc. (NASDAQ:AXGN), Institutional Investors Have a Lot Riding on the Business
Key Insights
關鍵洞察
- Institutions' substantial holdings in Axogen implies that they have significant influence over the company's share price
- A total of 10 investors have a majority stake in the company with 52% ownership
- Analyst forecasts along with ownership data serve to give a strong idea about prospects for a business
- 機構在AxoGen的重大持股意味着他們對公司股價有顯著影響。
- 共有10位投資者在公司中擁有52%的控股權。
- 分析師的預測以及持有數據有助於強烈理解業務的前景
Every investor in Axogen, Inc. (NASDAQ:AXGN) should be aware of the most powerful shareholder groups. The group holding the most number of shares in the company, around 78% to be precise, is institutions. Put another way, the group faces the maximum upside potential (or downside risk).
每位AxoGen, Inc.(納斯達克:AXGN)的投資者都應該意識到最強大的股東群體。持有公司最多股份的群體,準確來說,約佔78%,是機構。換句話說,該群體面臨着最大的潛在上行(或下行風險)。
And things are looking up for institutional investors after the company gained US$65m in market cap last week. The one-year return on investment is currently 123% and last week's gain would have been more than welcomed.
在公司上週市值增加6500萬美元后,機構投資者的前景變得更加樂觀。目前一年的投資回報率爲123%,上週的漲幅無疑是受歡迎的。
In the chart below, we zoom in on the different ownership groups of Axogen.
在下面的圖表中,我們聚焦於AxoGen的不同股權結構。
What Does The Institutional Ownership Tell Us About Axogen?
機構持股對AxoGen意味着什麼?
Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the register, especially if they are growing.
機構通常在向自己的投資者報告時,會與基準進行比較,因此一旦股票被納入主要指數,他們通常對該股票會更加熱情。我們預期大多數公司在登記時都會有一些機構,尤其是當它們正在增長時。
As you can see, institutional investors have a fair amount of stake in Axogen. This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong. If multiple institutions change their view on a stock at the same time, you could see the share price drop fast. It's therefore worth looking at Axogen's earnings history below. Of course, the future is what really matters.
正如您所看到的,機構投資者在AxoGen中擁有相當的股份。這意味着爲這些機構工作的分析師對該股票進行了研究,並且他們看好它。但是就像其他人一樣,他們也可能是錯誤的。如果多家機構同時改變對一隻股票的看法,您可能會看到股價迅速下跌。因此,查看AxoGen的盈利歷史是非常值得的。當然,未來才是真正重要的。
Since institutional investors own more than half the issued stock, the board will likely have to pay attention to their preferences. It would appear that 6.8% of Axogen shares are controlled by hedge funds. That's interesting, because hedge funds can be quite active and activist. Many look for medium term catalysts that will drive the share price higher. Looking at our data, we can see that the largest shareholder is First Light Asset Management, LLC with 9.9% of shares outstanding. In comparison, the second and third largest shareholders hold about 7.8% and 6.8% of the stock.
由於機構投資者擁有超過一半的已發行股票,董事會可能需要關注他們的偏好。看起來有6.8%的AxoGen股票被對沖基金控制。這很有趣,因爲對沖基金可能會相當活躍並採取激進措施。許多人尋找中期催化劑,以推動股價上漲。根據我們的數據,最大股東是First Light 資產管理公司,持有9.9%的流通股份。相比之下,第二和第三大的股東分別持有大約7.8%和6.8%的股票。
On further inspection, we found that more than half the company's shares are owned by the top 10 shareholders, suggesting that the interests of the larger shareholders are balanced out to an extent by the smaller ones.
進一步檢查發現,公司超過一半的股份由前10大股東持有,這表明大股東的利益在一定程度上被小股東所平衡。
Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be achieved by studying analyst sentiments. Quite a few analysts cover the stock, so you could look into forecast growth quite easily.
研究機構的持股是一種很好的方式,可以評估和篩選股票的預期表現。通過研究分析師的情緒也可以實現同樣的目標。相當多的分析師覆蓋了這隻股票,您可以很容易地查找預測增長。
Insider Ownership Of Axogen
AxoGen的內部持股情況
The definition of an insider can differ slightly between different countries, but members of the board of directors always count. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO.
內部人的定義在不同國家之間可能略有不同,但董事會成員始終被算作內部人。管理層最終向董事會負責。然而,管理者成爲執行董事會成員並不罕見,特別是當他們是創始人或首席執行官時。
I generally consider insider ownership to be a good thing. However, on some occasions it makes it more difficult for other shareholders to hold the board accountable for decisions.
我通常認爲內部人擁有股份是一件好事。然而,在某些情況下,這使得其他股東更難讓董事會對決策負責。
Shareholders would probably be interested to learn that insiders own shares in Axogen, Inc.. As individuals, the insiders collectively own US$32m worth of the US$654m company. It is good to see some investment by insiders, but it might be worth checking if those insiders have been buying.
股東們可能會對了解到內幕人士擁有AxoGen, Inc.的股份感興趣。作爲個人,內幕人士共同擁有3200萬美元的股份,佔公司65400萬美元的總價值。看到內幕人士進行一定的投資是件好事,但可能值得檢查一下這些內幕人士是否在買入。
General Public Ownership
公衆持股
The general public, who are usually individual investors, hold a 11% stake in Axogen. While this size of ownership may not be enough to sway a policy decision in their favour, they can still make a collective impact on company policies.
一般公衆,通常是個人投資者,在AxoGen中持有11%的股份。雖然這種規模的所有權可能不足以影響政策決定,但他們仍然可以對公司政策產生集體影響。
Next Steps:
下一步:
While it is well worth considering the different groups that own a company, there are other factors that are even more important. Take risks for example - Axogen has 1 warning sign we think you should be aware of.
儘管考慮擁有一家公司不同群體是值得注意的,但還有其他更重要的因素。以風險爲例——AxoGen有1個我們認爲您應該注意的警告信號。
Ultimately the future is most important. You can access this free report on analyst forecasts for the company.
最終,未來是最重要的。您可以訪問此免費的關於公司分析師預測的報告。
NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.
注意:本文中的數字是根據過去十二個月的數據計算得出的,指的是截至財務報表日期的月份最後一天的12個月期間。這可能與完整年度的年報數字不一致。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對本文有反饋?對內容有疑慮?請直接與我們聯繫。或者,發送電子郵件至 editorial-team (at) simplywallst.com。
這篇來自Simply Wall ST的文章是一般性的。我們根據歷史數據和分析師預測提供評論,採用無偏見的方法,我們的文章並不旨在提供財務建議。它不構成對任何股票的買入或賣出建議,也未考慮到您的目標或財務狀況。我們旨在爲您提供以基本數據驅動的長期分析。請注意,我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall ST在提到的任何股票中均沒有持倉。